Lexicon Pharmaceuticals LXRX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$50.34M+74.9% | -$200.4M-13.1% | -$177.12M-73.7% | -$101.94M-16.2% | ||
| $621K+16.3% | $534K-3.6% | $554K+29.7% | $427K+46.2% | ||
| $12.52M-7.3% | $13.5M-5.9% | $14.34M+24.5% | $11.52M+8.9% | ||
| $1.7M-7.9% | $1.85M+4.0% | $1.77M+139% | $741K+1,272% | ||
| —— | $2.46M— | —— | —— | ||
| $50K+133% | -$150K-139% | $381K— | —— | ||
| —— | $14.8M— | —— | $76K+100% | ||
| —— | -$598K— | —— | —— | ||
| $1.74M+315% | -$812K+46.3% | -$1.51M— | —— | ||
| —— | -$178.78M-10.4% | -$161.9M-82.2% | -$88.85M-2.1% | ||
| $139.84M-57.5% | $328.75M+47.2% | $223.34M+66.7% | $133.95M+291% | ||
| $252.86M-19.6% | $314.4M+80.8% | $173.87M+171% | $64.2M+70.8% | ||
| $113.02M— | —— | —— | —— | ||
| $48M— | —— | $0+100% | -$48.87M-518% | ||
| $0— | $0— | —— | $94.21M+159% | ||
| —— | —— | $824K— | —— | ||
| $0— | —— | $0— | $0— | ||
| -$48.5M— | —— | —— | $142.21M— | ||
| -$3.33M— | —— | -$25.23M— | —— | ||
| $8.33M-35.5% | $12.92M+28.5% | $10.06M+339% | $2.29M+186% | ||
| $3.71M-60.1% | $9.31M— | —— | $0— | ||
| $1.7M-7.9% | $1.85M+4.0% | $1.77M+139% | $741K+1,272% | ||
| -$757K+34.3% | -$1.15M— | —— | —— | ||
| —— | -$598K— | —— | —— | ||
| $1.74M+315% | -$812K+46.3% | -$1.51M— | —— | ||
| $252.86M-19.6% | $314.4M+80.8% | $173.87M+171% | $64.2M+70.8% | ||
| $0— | —— | $0— | $0— | ||
| $73K— | —— | —— | $0— | ||
| $48M— | —— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lexicon Pharmaceuticals generate?
- Lexicon Pharmaceuticals (LXRX) generated -$99.6M in operating cash flow over the trailing twelve months.
- Where does Lexicon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
